Loading…
Synthesis of deuterium labeled NMDA receptor inhibitor – 20-Oxo-5β-[9,12,12- 2H 3]pregnan-3α-yl- l-glutamyl 1-ester
[Display omitted] ► Synthesis of the deuterated inhibitor of NMDA receptor. ► Efficient method for introduction of three deuterium atoms into positions 9 and 12 of steroid skeleton. ► Deoxygenation of 11-hydroxy substituent via the Barton–McCombie reaction. 20-Oxo-5β-[9,12,12- 2H 3]pregnan-3α-yl- l-...
Saved in:
Published in: | Steroids 2012-02, Vol.77 (3), p.282-287 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | [Display omitted]
► Synthesis of the deuterated inhibitor of NMDA receptor. ► Efficient method for introduction of three deuterium atoms into positions 9 and 12 of steroid skeleton. ► Deoxygenation of 11-hydroxy substituent via the Barton–McCombie reaction.
20-Oxo-5β-[9,12,12-
2H
3]pregnan-3α-yl-
l-glutamyl 1-ester
11 was synthesized as an internal standard for quantification of a neuroprotective NMDA receptor ligand, 20-oxo-5β-pregnan-3α-yl-
l-glutamyl 1-ester
18 and its metabolites, in plasma and tissue. 11α-Hydroxy-progesterone (
1) was reduced under basic conditions to yield the corresponding 5β-steroid. Protection of the 3- and 20-oxo groups and oxidation of the 11α-hydroxy group was then followed by a deuterium exchange, conducted under basic conditions using deuterated methanol. Next, the carbonyl moiety at C-11 was reduced and the 11α-hydroxyl group removed through utilization of the Barton–McCombie reaction. Subsequent deprotection of the 3- and 20-acetals and stereoselective reduction of the 3-oxo group gave the desired trideuterated pregnanolone (
8). This was coupled with protected glutamic acid, which was then deprotected to yield [9,12,12-
2H
3]-pregnanolone glutamate (
11) with >99% isotopic purity. |
---|---|
ISSN: | 0039-128X 1878-5867 |
DOI: | 10.1016/j.steroids.2011.12.019 |